David Crispino Volpe is CFO at AdvanSource Biomaterials Corp (ASNB). They have made 7 open-market trades across 1 company since 2012, most recently 2013-12-03.
CIK 0001558093
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $5K since 2012, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ASNB | 140,153 | — |
Shares reported on the most recent Form 4, priced at the 2013-12-06 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ASNB | BUY | 2013-12-03 | 2013-12-06 | $0.05 | $1K | N/A | N/A | N/A |
| ASNB | BUY | 2013-08-29 | 2013-09-03 | $0.06 | $600 | N/A | N/A | N/A |
| ASNB | BUY | 2012-12-06 | 2012-12-10 | $0.03 | $300 | N/A | N/A | N/A |
| ASNB | BUY | 2012-11-30 | 2012-12-04 | $0.03 | $150 | N/A | N/A | N/A |
| ASNB | BUY | 2012-11-29 | 2012-12-03 | $0.04 | $200 | N/A | N/A | N/A |
| ASNB | BUY | 2012-11-19 | 2012-11-21 | $0.04 | $1K | N/A | N/A | N/A |
| ASNB | BUY | 2012-09-17 | 2012-09-19 | $0.02 | $2K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.